Anzeige
Mehr »
Dienstag, 02.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCV Sciences, Inc.: CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus338Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCESS...
► Artikel lesen
13.08.CV Sciences, Inc. - 10-Q, Quarterly Report2
13.08.Earnings Call: CV Sciences erzielt im zweiten Quartal 2025 höchste Bruttomarge seit 20191
13.08.CV Sciences Non-GAAP EPS of $0.00, revenue of $3.62M2
13.08.CV Sciences, Inc. Reports Second Quarter 2025 Financial Results227SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
CV SCIENCES Aktie jetzt für 0€ handeln
13.08.CV Sciences, Inc. - 8-K, Current Report6
08.08.CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025478SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
► Artikel lesen
24.06.CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3337SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
05.06.CV Sciences, Inc. - 8-K, Current Report-
14.05.CV Sciences targets cost efficiency gains and product diversification with in-source manufacturing and non-cannabinoid launches2
14.05.CV Sciences, Inc. - 10-Q, Quarterly Report1
14.05.CV Sciences, Inc. Reports First Quarter 2025 Financial Results300SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
14.05.CV Sciences, Inc. - 8-K, Current Report3
10.05.CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025385SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
28.03.CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call Transcript1
27.03.CV Sciences, Inc. - 10-K, Annual Report1
27.03.CV Sciences targets profitability with new product lines and M&A strategy in 20253
27.03.CV Sciences, Inc. - 8-K, Current Report2
27.03.CV Sciences Non-GAAP EPS of -$0.01, revenue of $15.71M3
27.03.CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results453SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
Weiter >>
27 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1